ArticleJournal of clinical medicine2026

Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCR.

Ayberk Bayramgil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.